Conjunctival Lymphoma

This entry looks at conjunctival lymphoma, also known as lymphoma of the conjunctiva, and maintained under the category 'Ocular Adnexal Lymphoma', one of the subtypes of lymphoma.

What is conjunctival lymphoma?

Conjunctival lymphoma is when lymphocytes turn cancerous in the conjunctiva, a mucous membrane that covers the whites of our eyes and the inner eyelids. Sometimes this cancer is secondary, meaning that it has reached the conjunctiva after starting elsewhere, but it is more commonly a primary cancer site. It is almost always of B-cell origin.

Lymphomas that develop in the eye (orbital lymphomas) are extremely rare, accounting for no more than one percent of all Non-Hodgkin lymphomas (NHLs) and about ten percent of extra-nodal NHLs.

Symptoms of conjunctival lymphoma

Symptoms of conjunctival lymphoma include eye irritation, pain in the eye, excessive tear production, and ptosis, or a dropping eyelid.

Conjunctival lymphoma treatment and prognosis

In general, when conjunctival lymphoma develops, it is one of two types: either a MALT lymphoma or a follicular lymphoma, and therefore a disease that follows an indolent or slow-growing course. Provided the disease is discovered in its early stage, the prognosis is considered very good and is treatable and sometimes even curable with radiotherapy. Additionally, if possible sometimes surgery is used to remove the tumor.

In the case of advanced conjunctival lymphoma, systemic chemotherapy followed by localized radiation has shown to control the lymphoma, but advanced disease in these cases has a much lower 5 year relative survival percentage than those found in early stages.

Sources

Bessel EM, Henk JM, Wright JE, Whitelocke RA. Orbital and conjunctival lymphoma: Treatment and prognosis. Radither Oncol 1988;13:237-44.

Fung CY et al. Ocular Adnexal Lymphoma: Clinical behaviour of distinct World Health Organization classification of subtypes. Int J Rad Oncol Biol Phys 2003;57:1382-91.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap